{{vm.title}}
25{{vm.includesText}}
{{item}}
{{vm.selectText}}
{{ vm.welcomeLabel.trim() }},
{{ vm.userName }}
{{ vm.text }}
{{vm.newUser1}} {{vm.newUser2}} {{vm.newUser3}} {{vm.newUser4}}
{{ vm.unknownUser }}
{{ vm.title }}
{{ vm.title }}
{{ vm.title }}
- {{ vm.siteSelectorList.flyout.cell1.heading }} {{ site.countryLocale }} {{ vm.siteSelectorList.flyout.cell1.global.countryLocale }}
{{ vm.closeTabLabel }}
- {{ vm.flyout.cell2.title }} {{ vm.flyout.cell2.newTabAllow }} {{ vm.flyout.cell2.title }}
- {{ vm.flyout.cell3.title }} {{ vm.flyout.cell3.newTabAllow }} {{ vm.flyout.cell3.title }}
- {{ vm.flyout.cell1.viewAll.label }} {{ vm.flyout.cell1.viewAll.newTabAllow }} {{ vm.flyout.cell1.viewAll.label }}
Legislative update: House passes COVID-19-related legislation (HEROES Act)
House passes COVID-19-related legislation (HEROES Act)
The U.S. House of Representatives this evening passed a bill (including an adopted managers’ amendment)—the ‘‘Health and Economic Recovery Omnibus Emergency Solutions Act’’ (HEROES Act) (H.R. 6800)—that includes measures intended to provide additional tax relief in response to the coronavirus (COVID-19) pandemic.
The vote was mostly along party lines, 208 to 199.
What’s next?
The outlook for the bill in the Senate is uncertain. The White House issued a Statement of Administration Policy [PDF 401 KB] indicating that if H.R. 6800 were to reach his desk, the president would be advised to veto the bill.
Overview of tax proposals
H.R. 6800 contains tax proposals, including several that would be applicable to businesses, such as:
- A provision that would make the limitation on excess business losses of non-corporate taxpayers permanent, effective retroactive to tax years beginning after 2017.
- A rule that would limit corporations from carrying back 2019 and 2020 net operating losses (NOLs) to years beginning prior to 2018. There would be further limitations on companies that have engaged in stock buybacks or that have paid certain amounts of executive compensation. The rule would be retroactive to the date of enactment of the CARES Act (March 27, 2020).
- A number of expansions and other modifications would be made to the employee retention credit that was enacted as part of the CARES Act, also retroactive to the date of enactment of the CARES Act.
- A new payroll tax credit would be made available with regard to certain expenses of employers subject to COVID-19-related closures.
The HEROES Act also includes certain other tax provisions that would apply for individual taxpayers, and would further provide for additional cash payments to be made to individuals.
Documents
- Read legislative text [PDF 3.78 MB] (1815 pages) as introduced
- Read a Managers Amendment [PDF 174 KB] (89 pages)
- Read a section-by-section summary [PDF 468 KB] of the proposed legislation, prepared by the Ways and Means Committee staff
- Read a one-page summary [PDF 328 KB] prepared by House Democratic leadership
- Read a revenue estimate of H.R. 6800 prepared by the Joint Committee on Taxation: JCX-15-20
- Read an updated JCT revenue estimate that includes the scores for retirement-related provisions: JCX-16-20 (released on May 28, 2020)
Proxy voting
A resolution (H. Res. 965) was approved, authorizing remote voting by proxy in the House of Representatives during the COVID-19 emergency. Read H.Res. 965
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.
